AVEOUnknown

AVEO PHARMACEUTICALS, INC. Insider Trading Activity

Every SEC Form 4 insider transaction reported for AVEO PHARMACEUTICALS, INC. (AVEO), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are AVEO insiders buying or selling?

AVEO PHARMACEUTICALS, INC. insiders reported 136 open-market buys ($164.6M) and 1 sells ($2.1M) across 137 Form 4 filings — a net buying position of $162.5M.

Source: SEC EDGAR Form 4

Key Statistics (as of Sep 3, 2021)

Total Form 4 filings
137
SEC EDGAR
Insider filers
15
Insider buys (136)
$164.6M
Insider sells (1)
$2.1M

Insider sentiment

Net buying

Net insider flow of $162.5M in net buying.

Recent AVEO insider transactions

DateInsiderRoleTypeSharesPriceValue
Sep 3, 2021Michael P BaileyPresident & CEOPurchase15.0K$6.48$97.2K
Aug 11, 2021Michael FerraressoChief Commercial OfficerPurchase2.6K$5.75$15.0K
Jun 22, 2020Peter W. Sonsini10% OwnerPurchase1.4M$5.25$7.5M
Jun 22, 2020Scott D Sandell10% OwnerPurchase1.4M$5.25$7.5M
Jun 22, 2020Joshua Makower10% OwnerPurchase1.4M$5.25$7.5M
Jun 22, 2020Mohamad Makhzoumi10% OwnerPurchase1.4M$5.25$7.5M
Jun 22, 2020Anthony A. Florence Jr.10% OwnerPurchase1.4M$5.25$7.5M
Jun 22, 2020Forest Baskett10% OwnerPurchase1.4M$5.25$7.5M
Jun 22, 2020Growth Equity Opportunities Fund IV, LLC10% OwnerPurchase1.4M$5.25$7.5M
Nov 25, 2019Michael P BaileyPresident & CEOPurchase150.0K$0.60$89.6K
Apr 8, 2019Peter W. Sonsini10% OwnerPurchase4.3M$1.14$5.0M
Apr 8, 2019Scott D Sandell10% OwnerPurchase4.3M$1.14$5.0M
Apr 8, 2019David M Mott10% OwnerPurchase4.3M$1.14$5.0M
Apr 8, 2019Joshua Makower10% OwnerPurchase4.3M$1.14$5.0M
Apr 8, 2019Mohamad Makhzoumi10% OwnerPurchase4.3M$1.14$5.0M
Apr 8, 2019Anthony A. Florence Jr.10% OwnerPurchase4.3M$1.14$5.0M
Apr 8, 2019Forest Baskett10% OwnerPurchase4.3M$1.14$5.0M
Apr 8, 2019Peter J Barris10% OwnerPurchase4.3M$1.14$5.0M
Apr 8, 2019Growth Equity Opportunities Fund IV, LLC10% OwnerPurchase4.3M$1.14$5.0M
Dec 22, 2018Peter W. Sonsini10% OwnerPurchase500.0K$1.55$774.4K
Dec 22, 2018Scott D Sandell10% OwnerPurchase500.0K$1.55$774.4K
Dec 22, 2018David M Mott10% OwnerPurchase500.0K$1.55$774.4K
Dec 22, 2018Joshua Makower10% OwnerPurchase500.0K$1.55$774.4K
Dec 22, 2018Mohamad Makhzoumi10% OwnerPurchase500.0K$1.55$774.4K
Dec 22, 2018Anthony A. Florence Jr.10% OwnerPurchase500.0K$1.55$774.4K

Showing the 25 most recent of 137 Form 4 filings for AVEO PHARMACEUTICALS, INC..

Most active AVEO insiders

  • Anthony A. Florence Jr.14 filings
  • Forest Baskett14 filings
  • Growth Equity Opportunities IV, LLC14 filings
  • Joshua Makower14 filings
  • Peter W. Sonsini14 filings

Ask anything about AVEO insider activity

Use Trabud's AI agent to query AVEO PHARMACEUTICALS, INC.'s Form 4 history in plain English — "Show me AVEO CEO purchases this year" or compare it against any other ticker.

Open the AI agent

AVEO insider trading FAQ

Are AVEO PHARMACEUTICALS, INC. insiders buying or selling?

Across 137 SEC Form 4 filings, AVEO PHARMACEUTICALS, INC. (AVEO) insiders reported 136 open-market purchases totaling $164.6M and 1 sales totaling $2.1M. That is a net buying position of $162.5M.

How many insiders trade AVEO stock?

15 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for AVEO PHARMACEUTICALS, INC.. The most recent filing was accepted on Sep 3, 2021.

Where does Trabud get AVEO insider trading data?

All AVEO insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content